Published in Int J Radiat Oncol Biol Phys on November 01, 1999
Predictive and prognostic models in radical prostatectomy candidates: a critical analysis of the literature. Eur Urol (2010) 1.30
Prediction of Gleason score upgrading in low-risk prostate cancers diagnosed via multi (> or = 12)-core prostate biopsy. World J Urol (2008) 1.23
How reliable is 12-core prostate biopsy procedure in the detection of prostate cancer? Can Urol Assoc J (2013) 1.09
Outcomes of men with an elevated prostate-specific antigen (PSA) level as their sole preoperative intermediate- or high-risk feature. BJU Int (2014) 0.83
Anti-Oligomannose Antibodies as Potential Serum Biomarkers of Aggressive Prostate Cancer. Drug Dev Res (2013) 0.83
Predictive models for worsening prognosis in potential candidates for active surveillance of presumed low-risk prostate cancer. Int Urol Nephrol (2011) 0.82
IGFBP-3 nuclear localization predicts human prostate cancer recurrence. Horm Cancer (2012) 0.81
Predictors of Gleason score upgrading in patients with prostate biopsy Gleason score ≤6. Can Urol Assoc J (2014) 0.81
Importance and determinants of Gleason score undergrading on biopsy sample of prostate cancer in a population-based study. BMC Urol (2013) 0.80
Predictors of Gleason Score (GS) upgrading on subsequent prostatectomy: a single Institution study in a cohort of patients with GS 6. Int J Clin Exp Pathol (2012) 0.79
Knife or needles? A cohort analysis of outcomes after radical prostatectomy or brachytherapy for men with low- or intermediate-risk adenocarcinoma of the prostate. Brachytherapy (2012) 0.79
Does the time from biopsy to radical prostatectomy affect Gleason score upgrading in patients with clinical t1c prostate cancer? Korean J Urol (2014) 0.77
Predicting the risk of harboring high-grade disease for patients diagnosed with prostate cancer scored as Gleason ≤ 6 on biopsy cores. World J Urol (2014) 0.76
Assessment of the Performance of Magnetic Resonance Imaging/Ultrasound Fusion Guided Prostate Biopsy against a Combined Targeted Plus Systematic Biopsy Approach Using 24-Core Transperineal Template Saturation Mapping Prostate Biopsy. Prostate Cancer (2016) 0.75
Importance of prostate-specific antigen (PSA) as a predictive factor for concordance between the Gleason scores of prostate biopsies and RADICAL prostatectomy specimens. Clinics (Sao Paulo) (2013) 0.75
Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA (1998) 21.31
Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst (1989) 5.28
Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves. J Urol (1994) 3.17
Biology and management of bladder cancer. N Engl J Med (1990) 2.60
Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst (1994) 2.50
Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer. J Clin Oncol (1999) 2.48
Refining the perfusion-diffusion mismatch hypothesis. Stroke (2005) 2.44
Self-regulating gene: an exact solution. Phys Rev E Stat Nonlin Soft Matter Phys (2005) 2.25
Transperineal magnetic resonance image guided prostate biopsy. J Urol (2000) 2.21
Acceleration of activation and inactivation by the beta subunit of the skeletal muscle calcium channel. Nature (1991) 2.18
The greatest dimension of prostate carcinoma is a simple, inexpensive predictor of prostate specific antigen failure in radical prostatectomy specimens. Cancer (1998) 2.14
The epidemiology of road accidents in childhood. Am J Public Health (1987) 2.12
Patient-reported impotence and incontinence after nerve-sparing radical prostatectomy. J Natl Cancer Inst (1997) 2.07
Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for clinically localized prostate cancer. JAMA (2000) 1.90
Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer. J Clin Oncol (2000) 1.86
Emotion knowledge as a predictor of social behavior and academic competence in children at risk. Psychol Sci (2001) 1.77
A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer. J Urol (1995) 1.74
Prognostic features of teratomas with malignant transformation: a clinicopathological study of 21 cases. J Urol (1998) 1.73
Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation. J Biol Chem (2001) 1.72
Urological complications of cyclophosphamide. J Urol (1989) 1.69
Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases. Am J Surg Pathol (1997) 1.69
DAZ family proteins exist throughout male germ cell development and transit from nucleus to cytoplasm at meiosis in humans and mice. Biol Reprod (2000) 1.64
Role of interleukin-6 in regulating synthesis of C-reactive protein and serum amyloid A in human hepatoma cell lines. Biochem Biophys Res Commun (1988) 1.55
Future prospects in prostate cancer. Prostate (1999) 1.53
Burned-out primary testicular cancer: sonographic and pathological characteristics. J Urol (1996) 1.49
Gender differences in smoking and risk for oral cancer. Cancer Res (1996) 1.47
Does smoking reduction result in reduction of biomarkers associated with harm? A pilot study using a nicotine inhaler. Nicotine Tob Res (2000) 1.46
The significance of subnormal serum vitamin B12 concentration in older people: a case control study. J Am Geriatr Soc (1996) 1.45
Sonography of the male genital tract. AJR Am J Roentgenol (1989) 1.45
Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging. Urology (2000) 1.44
Review of an 8-year experience with modifications of endoscopic suspension of the bladder neck for female stress urinary incontinence. J Urol (1990) 1.43
Rational approach to evaluation and management of spontaneous perirenal hemorrhage. Surg Gynecol Obstet (1990) 1.42
Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine. Cancer Epidemiol Biomarkers Prev (1995) 1.42
Correction and refinement of the genetic map of bacteriophage Mu. Virology (1979) 1.41
Clinicopathological characteristics of prostatic adenocarcinoma in men with atypical prostate needle biopsies. J Urol (1998) 1.39
Optimizing patient selection for dose escalation techniques using the prostate-specific antigen level, biopsy gleason score, and clinical T-stage. Int J Radiat Oncol Biol Phys (1999) 1.39
Short and long-term morbidity of thoracoabdominal incision for nephrectomy: a comparison with the flank approach. J Urol (1999) 1.39
Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am J Surg Pathol (2000) 1.38
Mentholated cigarettes and smoking habits in whites and blacks. Tob Control (2002) 1.37
Myelolipoma of the renal sinus. An unusual site for a rare extra- adrenal lesion. Arch Pathol Lab Med (1999) 1.33
The determination of glutathione, cyst(e)ine, and other thiols and disulfides in biological samples using high-performance liquid chromatography with dual electrochemical detection. Anal Biochem (1987) 1.29
The musculo-skeletal examination: a neglected clinical skill. Aust N Z J Med (1991) 1.28
Testicular self-examination. N Engl J Med (1980) 1.27
Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen era. J Urol (2001) 1.27
Expression of cell cycle-regulated proteins in prostate cancer. Cancer Res (1996) 1.23
Lessons from tumor progression: the invasive radial growth phase of melanoma is common, incapable of metastasis, and indolent. J Invest Dermatol (1993) 1.23
Transforming growth factor beta 1 regulates production of acute-phase proteins. Proc Natl Acad Sci U S A (1990) 1.23
Heparin-binding EGF-like growth factor is an autocrine growth factor for human urothelial cells and is synthesized by epithelial and smooth muscle cells in the human bladder. J Clin Invest (1997) 1.21
Endorectal magnetic resonance imaging as a predictor of biochemical outcome after radical prostatectomy in men with clinically localized prostate cancer. J Urol (2000) 1.20
Palliative irradiation for focally symptomatic metastatic renal cell carcinoma: support for dose escalation based on a biological model. J Urol (1997) 1.20
Volume-overload cardiac hypertrophy is unaffected by ACE inhibitor treatment in dogs. Am J Physiol (1997) 1.17
Subcapsular hematoma of the liver. Nonoperative management. Arch Surg (1972) 1.17
Heterogeneous nature of the acute phase response. Differential regulation of human serum amyloid A, C-reactive protein, and other acute phase proteins by cytokines in Hep 3B cells. J Immunol (1988) 1.16
Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study. J Clin Oncol (1998) 1.16
Life span profiles of glutathione and acetaminophen detoxification. Drug Metab Dispos (1991) 1.15
Monokines regulate glycosylation of acute-phase proteins. J Exp Med (1987) 1.15
Predictors of positive retroperitoneal lymph nodes in patients with high risk testicular cancer. J Urol (2011) 1.14
Perineural invasion as a predictor of biochemical outcome following radical prostatectomy for select men with clinically localized prostate cancer. J Urol (2001) 1.14
Treatment of renal cell carcinoma in von Hippel-Lindau disease: a multicenter study. J Urol (1995) 1.13
Endorectal coil magnetic resonance imaging identifies locally advanced prostate cancer in select patients with clinically localized disease. Urology (1998) 1.13
CT and ultrasound features of metanephric adenoma in adults with pathologic correlation. J Comput Assist Tomogr (1999) 1.13
Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients. J Natl Cancer Inst (1993) 1.12
Aggressive surgical approach to renal cell carcinoma: review of 130 cases. J Urol (1979) 1.12
Perineural invasion is associated with increased relapse after external beam radiotherapy for men with low-risk prostate cancer and may be a marker for occult, high-grade cancer. Int J Radiat Oncol Biol Phys (2004) 1.12
Status of glutathione and other thiols and disulfides in human plasma. Biochem Pharmacol (2000) 1.11
CYP1A1 and GSTM1 polymorphisms and oral cancer risk. Cancer Epidemiol Biomarkers Prev (1997) 1.10
Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines. Cancer Res (1980) 1.09
Urologic complications of appendicitis. Urology (1975) 1.09
Results of inferior vena cava resection for renal cell carcinoma. J Urol (1981) 1.09
Effects of watercress consumption on metabolism of a tobacco-specific lung carcinogen in smokers. Cancer Epidemiol Biomarkers Prev (1995) 1.08
Intravesical doxorubicin for prophylaxis in the management of recurrent superficial bladder carcinoma. J Urol (1984) 1.07
Changing concepts in the treatment of nonseminomatous germ cell tumors of the testis. J Urol (1984) 1.07
Utilizing predictions of early prostate-specific antigen failure to optimize patient selection for adjuvant systemic therapy trials. J Clin Oncol (2000) 1.07
Evaluation of the Confusion Assessment Method (CAM) as a screening tool for delirium in the emergency room. Gen Hosp Psychiatry (2001) 1.07
Medicine in the USSR. West J Med (1988) 1.05
Comparison of GSTM polymorphisms and risk for oral cancer between African-Americans and Caucasians. Pharmacogenetics (2000) 1.05
Ureteral obstruction secondary to metastatic tumors. Surg Gynecol Obstet (1979) 1.04
Treatment and surgical staging of testicular and primary extragonadal germ cell cancer. JAMA (1983) 1.04
Urinary diversion: the physiological rationale for non-refluxing colonic conduits. Br J Urol (1975) 1.03
The Juvenile Arthritis Quality of Life Questionnaire--development of a new responsive index for juvenile rheumatoid arthritis and juvenile spondyloarthritides. J Rheumatol (1997) 1.03
Partial nephrectomy: alternative treatment for selected patients with renal cell carcinoma. Urology (1998) 1.02
Metanephric adenoma-like tumors of the kidney: report of 3 malignancies with emphasis on discriminating features. Arch Pathol Lab Med (1999) 1.01
The acute phase response is mediated by heterogeneous mechanisms. Ann N Y Acad Sci (1989) 1.01
Psychosocial factors, curative therapies, and behavioral outcomes. A comparison of testis cancer survivors and a control group of healthy men. Cancer (1989) 1.01
Cytologic and cytogenetic analysis of metanephric adenoma of the kidney: a report of two cases. Am J Clin Pathol (1997) 1.01
A prostate gland volume of more than 75 cm3 predicts for a favorable outcome after radical prostatectomy for localized prostate cancer. Urology (1998) 0.99
Accuracy of digital rectal examination and transrectal ultrasonography in localizing prostate cancer. J Urol (1994) 0.99